secwatch.observer — SEC 8-K summary
======================================

Issuer:     PepGen Inc. (PEPG)
CIK:        0001835597
Form:       8-K
Filed at:   2025-09-26T23:59:59+00:00
Accession:  0001193125-25-218503
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud

PepGen Inc. prices $100 million public offering of 31.25 million shares at $3.20 per share
--------------------------------------------------------------------------------

- PepGen entered into underwriting agreement with Leerink Partners and Stifel to sell 31,250,000 shares at $3.20 per share.
- Underwriters exercised in full their 30-day option to purchase an additional 4,687,500 shares.
- Net proceeds estimated at $107.6 million to fund FREEDOM-DM1 and FREEDOM2-DM1 clinical trials and for working capital.
- Offering expected to close on September 26, 2025, subject to customary conditions.
- Securities offered under an effective shelf registration statement filed with the SEC on June 28, 2024.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1835597/000119312525218503/0001193125-25-218503-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1835597/000119312525218503/d911432d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-218503

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer